Dipl. Ing. Martin Piskáček, Dr. rer. nat.
Head of the research group, Martin Piskáček Group: Transcription in Malignant Cells and Immunity
Office: bldg. A18/305
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 6697 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 43
2022
-
Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
Frontiers in Cellular Neuroscience, year: 2022, volume: 16, edition: February 2022, DOI
-
CMV-reactive Vdelta1 gd T cells are equally cytotoxic to CMV-specific ab T cells in HLA-A*02 healthy donors
Year: 2022, type: Conference abstract
-
Cryptic inhibitory regions nearby activation domains
Biochimie, year: 2022, volume: 200, edition: September 2022, DOI
-
Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients
Year: 2022, type: Conference abstract
-
Tumor infiltration of gamma-delta T cells in glioblastoma
Year: 2022, type: Conference abstract
2021
-
Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing
Frontiers in Immunology, year: 2021, volume: 12, edition: October 2021, DOI
-
Gamma-delta T cells in Glioblastoma patients
Year: 2021, type: Conference abstract
-
Gamma-delta T cells in Glioblastoma patients
Year: 2021, type:
-
Infiltration of Gamma-delta T cells into Glioblastoma Tumor
Year: 2021, type: Conference abstract
-
Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
Journal of Clinical Medicine, year: 2021, volume: 10, edition: 16, DOI